IP Library Granted Patent US 10,975,398
Granted Patent B2
US 10,975,398 · App. 16/664,378 · Granted Apr 13, 2021

Heterologous production of 10-methylstearic acid

Inventors: Arthur J. Shaw (Belmont, MA); Hannah Blitzblau (Arlington, MA); Donald V. Crabtree (Cambridge, MA)
Assignee: Ginkgo Bioworks, Inc.
C12P7/6409A23D9/02C11B1/10C11C3/00C12N9/001C12N9/1007C12Q1/686
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,975,398
App. No.
16/664,378
Granted
Apr 13, 2021
Kind
B2
Abstract

Nucleic acids and cells comprising a methyltransferase gene and/or a reductase gene are disclosed. These nucleic acids and cells may be used to produce branched (methyl)lipids, such as 10-methylstearate.

Claims (19)

1. A method of producing a branched (methyl)lipid or an exomethylene-substituted lipid comprising contacting a yeast cell with oleic acid, methionine, or both oleic acid and methionine,

wherein the branched (methyl)lipid or the exomethylene-substituted lipid is a carboxylic acid, carboxylate, ester, thioester, or amide,

wherein (a) the branched (methyl)lipid comprises (i) a saturated branched aliphatic chain comprising a branching methyl group or (ii) an unsaturated branched aliphatic chain comprising a branching methyl group, or (b) the exomethylene-substituted lipid comprises a branched aliphatic chain wherein the branched aliphatic chain is substituted with an exomethylene group,

wherein the yeast cell comprises a methyltransferase gene encoding a Thermomonospora curvata tmsB enzyme, and

wherein the yeast cell produces the branched (methyl)lipid or the exomethylene-substituted lipid.

2. The method of claim 1 , wherein the branched (methyl)lipid or the exomethylene-substituted lipid comprises a linear lipid with a chain length of 14-20 carbons and a methyl branch at the Δ9 position, the Δ10 position, or the Δ11 position.

3. The method of claim 2 , wherein the branched (methyl)lipid or the exomethylene-substituted lipid is a diacylglycerol, a triacylglycerol, or a phospholipid, and wherein the diacylglycerol, triacylglycerol, or phospholipid comprises an ester of 10-methylstearate or an ester of 10-methylenestearate.

4. The method of claim 1 , wherein at least 1% by weight of fatty acids of the yeast cell are one or more linear fatty acids with a chain length of 14-20 carbons and a methyl branch at the Δ9 position, the Δ10 position, or the Δ11 position.

5. The method of claim 1 , wherein the yeast cell comprises at least 1% lipid as measured by % dry cell weight.

6. The method of claim 1 , wherein the yeast cell further comprises a recombinant reductase gene.

7. The method of claim 6 , wherein the recombinant reductase gene encodes tmsA from Thermomonospora curvata.

8. The method of claim 6 , wherein the yeast cell encodes a fusion protein comprising (A) a reductase protein encoded by the recombinant reductase gene and (B) the tmsB enzyme.

9. The method of claim 1 , wherein the methyltransferase gene is codon-optimized for the yeast cell, or wherein the yeast cell further comprises a reductase gene and the reductase gene is codon-optimized for the yeast cell.

10. The method of claim 1 , wherein the yeast cell is Arxula, Saccharomyces , or Yarrowia.

11. The method of claim 10 , wherein the yeast cell is Arxula adeninivorans, Saccharomyces cerevisiae , or Yarrowia lipolytica.

12. The method of claim 1 , wherein the yeast cell comprises a methyltransferase protein encoded by the methyltransferase gene, wherein the methyltransferase protein comprises an amino acid sequence with at least 95% sequence identity with the amino acid sequence of SEQ ID NO:76.

13. The method of claim 12 , wherein the yeast cell comprises a methyltransferase protein encoded by the methyltransferase gene, wherein the methyltransferase protein comprises the amino acid sequence of SEQ ID NO:76.

14. The method of claim 1 , wherein the methyltransferase gene comprises a nucleotide sequence with at least 95% sequence identity with the nucleotide sequence of SEQ ID NO:75.

15. The method of claim 14 , wherein the methyltransferase gene comprises the nucleotide sequence of SEQ ID NO:75.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE FIRST ASSIGNOR'S NAME PREVIOUSLY RECORDED ON REEL 051521 FRAME 0317. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNOR'S NAME IS ARTHUR J. SHAW. Recorded Nov 17, 2020
From: SHAW, ARTHUR J.; BLITZBAU, HANNAH; CRABTREE, DONALD V.
To: NOVOGY, INC.
Reel/Frame 054450/0989 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 054142 FRAME: 0171. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Nov 17, 2020
From: NOVOGY, INC.
To: GINKGO BIOWORKS, INC.
Reel/Frame 054451/0918 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2020
From: NOVOGY, INC.
To: GINKGO BIOWORKS, INC
Reel/Frame 054142/0171 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2020
From: SHAW, ARTHUR J., IV; BLITZBLAU, HANNAH; CRABTREE, DONALD V.
To: NOVOGY, INC.
Reel/Frame 051521/0317 →
Continuity (3)
Division 15710734 · Sep 20, 2017
Provisional Application 62396870 · Sep 20, 2016
Related Publication 20200123579A1 · Apr 23, 2020